Clinical trials
Phase 2 Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
209 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 11 |
| 2003 | 3 |
| 2004 | 2 |
| 2005 | 12 |
| 2006 | 14 |
| 2007 | 6 |
| 2008 | 14 |
| 2009 | 14 |
| 2010 | 9 |
| 2011 | 8 |
| 2012 | 6 |
| 2014 | 4 |
| 2015 | 7 |
| 2016 | 2 |
| 2017 | 6 |
| 2018 | 7 |
| 2019 | 8 |
| 2020 | 10 |
| 2021 | 8 |
| 2022 | 11 |
| 2023 | 11 |
| 2024 | 10 |
| 2025 | 8 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 97 |
| Recruiting | 31 |
| Terminated | 25 |
| Unknown status | 22 |
| Active, not recruiting | 13 |
| Withdrawn | 12 |
| Not yet recruiting | 8 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 13 |
| Eli Lilly and Company | 8 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 8 |
| Pfizer | 7 |
| National Cancer Institute (NCI) | 6 |
| Amgen | 5 |
| H. Lee Moffitt Cancer Center and Research Institute | 4 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| AstraZeneca | 3 |
| ECOG-ACRIN Cancer Research Group | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 209 |
| Neoplasms | 60 |
| Carcinoma, Non-Small-Cell Lung | 35 |
| Neoplasm Metastasis | 30 |
| Adenocarcinoma | 24 |
| Neoplasms by Site | 18 |
| Lung Neoplasms | 17 |
| Neoplasms, Glandular and Epithelial | 17 |
| Squamous Cell Carcinoma of Head and Neck | 17 |
| Head and Neck Neoplasms | 14 |
Trials
Showing 76 to 100 of 209. Each trial links to its page on Pharma Observatory.
109 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.